C12N 2710/16262
By genetic engineering
Official title: by genetic engineering
C12N2710/16262 (By genetic engineering) appears on 8 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 3
- Assignees
- 5
- Inventors
- 11
- Latest grant
- 28 May 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Epstein-Barr-virus vaccine28 May 2019US 10,300,129 B2Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmb)
- Second generation virus-like particles (VLP) from Epstein-Barr viruses for vaccination purposes13 Dec 2016US 9,517,261 B2Deutsches Krebsforschungszentrum
- Recombinant adeno-associated virus vectors14 Jul 1998US 5,780,280 ARhone-Poulenc Rorer Pharmaceuticals Inc.
- Recombinant adeno-associated virus vector packaging cells and methods for use25 Nov 1997US 5,691,176 AApplied Immune Sciences, Inc.
- Method for producing recombinant adeno-associated virus vectors28 Oct 1997US 5,681,731 AApplied Immune Sciences, Inc.
- Epstein-barr-virus vaccine13 Oct 2016US 2016/0296618 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Second generation virus-like particles (vlp) from epstein-barr viruses for vaccination purposes30 Oct 2014US 2014/0322255 A1Deutsches Krebsforschungszentrum
- Epstein-barr-virus vaccine14 Aug 2014US 2014/0227305 A1
Most cited
By later US patents
- Production of recombinant adeno-associated virus vectors369US 5,173,414 AApplied Immune Sciences, Inc. · 1992
- Recombinant adeno-associated virus vector packaging cells and methods for use86US 5,691,176 AApplied Immune Sciences, Inc. · 1997
- Production of recombinant adeno-associated virus vectors75US 5,354,678 AApplied Immune Sciences, Inc. · 1994
- Recombinant adeno-associated virus vectors46US 5,589,377 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Method for producing recombinant adeno-associated virus vectors27US 5,681,731 AApplied Immune Sciences, Inc. · 1997